Evaluation of Immunoglobulin-A Level in Children with Acute Lymphoblastic Leukemia

Authors

  • Azam Hashemi Hematology and Oncology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  • Elham Akhondzadeh Department of Pediatric, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  • Fatemeh Ghanizadeh
  • M Mirakhor Department of Pediatric, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  • Razieh Akhond Zardini Infectious Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  • Robab Sheikhpour Hematology and Oncology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  • Zohreh Khanjarpanah Department of Pediatric, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Abstract:

Background: Acute lymphoblastic leukemia (ALL) is the most common type of leukemia among children. Immunoglobulin A is the most numerous immunoglobulin isotype in mucosal secretion.&nbsp; Immunoglobulin A (IgA) deficiency can increase risk of cancer in patients. Since few studies have been done on relation between serum IgA and ALL, this study was attempted to evaluate serum IgA in ALL patients. Materials and Methods: In this descriptive analytical study, 28 pediatric patients diagnosed with ALL with mean age of 6.75&plusmn; 3.29 ranged from 1 to11 years old and 28 controls with mean age of 7.31&plusmn; 4.12 ranged from 2 to 12 years old were chosen from Shahid Sadoughi Hospital. Serum IgA was measured by immunotorbidometric method (Pars Azmoon Kit, Iran). Pearson and Independent t test were used for the analysis of data. Results: In this study, the mean level of IgA was lower in patients with ALL (82.5&plusmn; 21.3 mg/dl) in comparison to control group (113.2&plusmn; 26.62 mg/dl). Moreover, there was significant difference between two groups (P<0.01). Regarding patients age, no significant difference was seen either (P>0.05). Conclusion: According to the results of the present study, the serum level of IgA was significantly lower in ALL pediatric patients than the control group; however, it was in normal range in both groups. More studies are needed to strongly conclude IgA deficiency as a new risk factor or as a new marker of ALL in children. Other immunoglobulins are recommended to be considered in patients with ALL in further studies.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Association of serum leptin level with obesity in children with acute lymphoblastic leukemia

Background Obesity is a medical problem in survivors of childhood acute lymphoblastic leukemia. Obesity is associated with many complications, so it is important to investigate the respective etiology. Leptin is a protein synthesized in the fatty tissue and is effective in the control of obesity. Survey of leptin in acute lymphoblastic leukemia (ALL) survivors could be helpful in controlling ob...

full text

Brain MRI Findings in Children with Acute Lymphoblastic Leukemia

Background: Patients with leukemia are facing more complications in order to achieve longer survival. We aimed to evaluate the frequency of central nervous system abnormalities (CNS) on MRI of children with acute lymphoblastic leukemia (ALL). Methods: Sixty-six children with diagnosis of ALL aged 2-18 years were recruited. Non-contrast sequences of brain MRI in addition to diffusion weighted i...

full text

Estimating The Density of Candida Albicans in Children with Acute Lymphoblastic Leukemia (A Pilot Study)

Introduction: Oral Candidosis is among the find-ings of acute leukemia. The aim of this study was to evaluate the changes in the intensity of C.albicans, before treatment and at the Induc-tion phase. &nbsp;Materials and Methods: Twelve patients with Acute Lymphoblastic Leukemia (ALL) aged 2-14 years enrolled in study. Whole Saliva samples were obtained and cultured to determine the mean count ...

full text

Evaluation of risk factors in children with acute lymphoblastic leukemia

The aim of the present study was to investigate the influence of some possible risk factors in development of ALL. A hundred and sixteen children diagnosed as ALL over a three year period in our institute were involved in the study. Their ages ranged between 1 and 14 years (7.35±3.8). Four hundred children without any malignant or chronic disorders served as the control group. Male sex, increas...

full text

FACTORS EFFECTIVE IN THE PROGNOSIS OF NEUTROPENIC FEVER IN THE CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Background & Aims: Febrile Neutropenia (FN) is one of the common complications of chemotherapy in the children with malignancy. In this study, we investigated the effective factors in response to the treatment of patients with febrile neutropenia. By using these factors, it is possible to have a better analysis about the severity of infection of these patients and it will helpful in choosing th...

full text

Expression of ROR1 Gene in Patients with Acute Lymphoblastic Leukemia

Background: Acute lymphoblastic leukemia (ALL) results from genetic alterations in a single lymphoid progenitor cell. Expression of ROR1 is reported to be increased in ALL and mantle cell lymphoma. In this study the expression of ROR1 was assessed in newly diagnosed patients with ALL.  Methods: This study was carried out on 40 patients with newly diagnosed ALL and healthy individuals as contro...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 7  issue 3

pages  149- 153

publication date 2017-07

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023